ストックスクリーナーアプリを入手
4.50
4.90%
0.21
アフターアワーズ：
4.50
前日終値:
$4.29
開ける：
$4.465
24時間の取引高:
12,489
Relative Volume:
0.47
時価総額：
$8.65M
収益：
$7.70M
当期純損益:
$-33.38M
株価収益率:
-0.3655
EPS:
-12.3134
ネットキャッシュフロー:
$-39.92M
1週間 パフォーマンス:
-2.91%
1か月 パフォーマンス:
-8.16%
6か月 パフォーマンス:
-18.63%
1年 パフォーマンス:
-46.43%
1日の値動き範囲:
$4.26
$4.55
1週間の範囲:
$4.21
$4.8784
52週間の値動き範囲:
$3.91
$9.376
Bolt Biotherapeutics Inc Stock (BOLT) Company Profile
名前
Bolt Biotherapeutics Inc
セクター
電話
650-665-9295
住所
900 CHESAPEAKE DRIVE, REDWOOD CITY
Compare BOLT vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BOLT
Bolt Biotherapeutics Inc
|
4.50 | 8.24M | 7.70M | -33.38M | -39.92M | -12.31 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-20 | 再開されました | H.C. Wainwright | Buy |
| 2022-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-03-02 | 開始されました | Guggenheim | Buy |
| 2021-03-02 | 開始されました | Morgan Stanley | Overweight |
| 2021-03-02 | 開始されました | SVB Leerink | Outperform |
| 2021-03-02 | 開始されました | Stifel | Buy |
すべてを表示
Bolt Biotherapeutics Inc (BOLT) 最新ニュース
CEO Change: Is Bolt Biotherapeutics Inc on track to beat earnings2026 Chart Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn
Bolt Biotherapeutics (BOLT) to Release Quarterly Earnings on Wednesday - Defense World
If You Invested $1,000 in Bolt Biotherapeutics, Inc. (BOLT) - Stock Titan
Buyout Rumor: Is Bolt Biotherapeutics Inc undervalued by DCF analysisInsider Buying & Technical Pattern Based Signals - baoquankhu1.vn
Market Outlook: Is Bolt Biotherapeutics Inc likely to announce a buybackEarnings Miss & Short-Term Swing Trade Alerts - baoquankhu1.vn
Market Leaders: Is Bolt Biotherapeutics Inc likely to announce a buyback2026 Action & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Sell Signal: Will Bolt Biotherapeutics Inc outperform its industry peersPortfolio Gains Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
What is the long term forecast for Bolt Biotherapeutics Inc stock2026 News Drivers & Fast Gain Stock Tips - baoquankhu1.vn
Weekly Earnings: Is Bolt Biotherapeutics Inc stock a smart retirement pick2026 Bull vs Bear & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Fundamentals Check: Does Bolt Biotherapeutics Inc have strong EBITDA margins2026 Bull vs Bear & Community Consensus Trade Signals - baoquankhu1.vn
Whats the outlook for Bolt Biotherapeutics Incs sector2026 Analyst Calls & Long Hold Capital Preservation Plans - baoquankhu1.vn
Market Outlook: Is Bolt Biotherapeutics Inc stock a smart retirement pick2026 Weekly Recap & High Conviction Trade Alerts - baoquankhu1.vn
HC Wainwright Reiterates Buy Rating for Bolt Biotherapeutics (BO - GuruFocus
Bolt Biotherapeutics Inc.: Q4 Earnings Snapshot - theheraldreview.com
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update - Bitget
Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Bolt Biotherapeutics Inc.: Fourth Quarter Financial Results Overview - Bitget
BOLT Reports Q4 Revenue Surpassing Expectations - GuruFocus
Bolt Biotherapeutics 10-K: $7.7M Revenue, $(17.85) EPS - TradingView
Bolt Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Cost cuts help Bolt Biotherapeutics (NASDAQ: BOLT) halve 2025 loss - Stock Titan
Bolt tests new gastric cancer drug, $31.8M cash into 2027 - Stock Titan
Take Profit: Is Bolt Biotherapeutics Inc a speculative investmentMarket Volume Report & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) Sees Large Growth in Short Interest - Defense World
Bolt Biotherapeutics, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Can Bolt Biotherapeutics Inc. stock maintain growth trajectoryEarnings Recap Report & Real-Time Market Trend Scan - Naître et grandir
Is Bolt Biotherapeutics Inc. (6LP0) stock overpriced at current multiplesDividend Hike & Step-by-Step Swing Trade Plans - Naître et grandir
BOLTBolt Biotherapeutics, Inc. Latest Stock News & Market Updates - Stock Titan
Is Bolt Biotherapeutics Inc likely to announce a buybackJuly 2025 Technicals & Reliable Trade Execution Plans - baoquankhu1.vn
BOLT SEC FilingsBolt Biotherapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Portfolio Update: Will Bolt Biotherapeutics Inc announce a stock splitJuly 2025 Selloffs & Reliable Intraday Trade Alerts - baoquankhu1.vn
Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy? - MSN
Bolt Biotherapeutics to Participate in Upcoming March Conferences - Bitget
Ideas Watch: Is Bolt Biotherapeutics Inc a speculative investmentProduct Launch & Technical Pattern Alert System - baoquankhu1.vn
BOLT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Layoff Tracker: Concerto Downsizes Amid Pivot to Consumer; Faraday Closes Down - BioSpace
Recap Report: Is TIM SA Depositary Receipt stock a hidden gemWeekly Profit Summary & Growth Focused Stock Pick Reports - baoquankhu1.vn
Is Bolt Biotherapeutics Inc. impacted by rising ratesIndex Update & Weekly Setup with ROI Potential - mfd.ru
Is Bolt Biotherapeutics Inc. likely to announce a buybackRecession Risk & Smart Money Movement Alerts - mfd.ru
Why Bolt Biotherapeutics Inc. (6LP0) stock stays undervaluedTrade Signal Summary & Community Supported Trade Ideas - mfd.ru
Is Bolt Biotherapeutics Inc. stock forming a cup and handleJuly 2025 Earnings & Intraday High Probability Setup Alerts - mfd.ru
Is Bolt Biotherapeutics Inc. a speculative investmentJuly 2025 WrapUp & Daily Profit Focused Screening - mfd.ru
H.C. Wainwright Raises Protagonist Therapeutics, Inc. (PTGX) Target to $117, Reiterates Buy - Finviz
Treasury Yields: Is Bolt Biotherapeutics Inc. a top pick in the sectorPortfolio Return Summary & AI Forecasted Stock Moves - baoquankhu1.vn
Radiopharm Theranostics (NASDAQ:RADX) versus Bolt Biotherapeutics (NASDAQ:BOLT) Head-To-Head Survey - Defense World
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Bolt Biotherapeutics (NASDAQ:BOLT) Stock Passes Above 200 Day Moving Average – Should You Sell? - Defense World
Growth Review: What are the analyst revisions for Bolt Biotherapeutics Inc.Is ZKIN stock a good investment in YEARDollar Strength & Low Risk High Reward Ideas - baoquankhu1.vn
Is Bolt Biotherapeutics Inc. still a buy after recent gains2025 Momentum Check & Free High Accuracy Swing Entry Alerts - mfd.ru
Insider Trends: What is the long term forecast for Bolt Biotherapeutics Inc stockJuly 2025 Chart Watch & AI Powered Market Entry Ideas - baoquankhu1.vn
Risk Recap: Can ETRACS 2x Leveraged US Value Factor TR ETN maintain sales growth2025 Trade Ideas & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Bolt Biotherapeutics Inc (BOLT) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):